These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5288944)

  • 1. [Experimental study of the tolerance of healthy tissues of the oral cavity to sarcolysine].
    Shental' VV
    Stomatologiia (Mosk); 1971; 50(6):29-32. PubMed ID: 5288944
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular architecture in oral tissues by vascular casts method for scanning electron microscopy.
    Ichikawa T; Watanabe O; Yamamura T
    Bibl Anat; 1977; (15 Pt 1):544-6. PubMed ID: 597214
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphological changes in the parotid gland and the adjacent tissues in the case of intracarotid injection of sarcolysin].
    Poliakov BI
    Stomatologiia (Mosk); 1973; 52(5):39-41. PubMed ID: 4517536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Distribution of novocaine and its effect on the capillary bed during intravenous and intra-arterial infusion in experiment].
    Gasparian SA; Samburskiĭ VI; Rykov VD
    Farmakol Toksikol; 1968; 31(5):576-9. PubMed ID: 5707729
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of NAD level in tumor and regenerating tissues on their sensitivity to sarcolysine].
    Sorokina IB; Oreshikova NA; Mal'kova VP; Novikova MA; Zhdanov GL
    Vopr Med Khim; 1965; 11(6):43-7. PubMed ID: 4289104
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study of the distribution of the antiblastic preparation ThioTep-S35 in different variants of its administration into the lingual artery].
    Shental' VV; Poliakov BI
    Stomatologiia (Mosk); 1969; 48(4):56-8. PubMed ID: 4980339
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the structure of DNA induced by sarcolysine in vivo and in vitro].
    Babaian IuC; Garibian DV; Danielian IS; Aslanian VM; Garibdzhanian BT
    Vopr Med Khim; 1984; 30(5):92-5. PubMed ID: 6528526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the regional chemotherapy of malignant neoplasms of organs of the thoracic cavity: distribution of intravenously and intra-arterially administered THIO-TEPA-S35 (experimental study)].
    Stranadko EF; Gasparian SA; Karev NI
    Grudn Khir; 1967; 9(5):103-6. PubMed ID: 4979437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interaction of sarcolysine with the DNA from tumorous and homologous normal tissues].
    Iamshanov VA
    Vopr Onkol; 1974; 20(3):69-73. PubMed ID: 4373914
    [No Abstract]   [Full Text] [Related]  

  • 10. [Formation of antibodies to sarcolysine and their influence on its antitumorous activity].
    Nikolaev AI; Akhmadieva AKh; Makarov GF
    Biull Eksp Biol Med; 1965 Jul; 60(7):95-8. PubMed ID: 5880716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of embitol and sarcolysine on the content of readily hydrolyzable of ATP and ADP phosphate in organs and tissues of rats].
    Savitskiĭ IV; Totskiĭ VN
    Vopr Med Khim; 1965; 11(4):28-34. PubMed ID: 5873837
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative cytogenetic study of the resistance of tumor cells to sarcolysine.
    Voitovitskii VK; Edygenova AK; Kabiev OK
    Sov Genet; 1971 Jun; 7(6):766-9. PubMed ID: 5163428
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effeco of sarcolysine on the growth and morphological characteristics of IMR-1 sarcoma].
    Svinogeeva TP; Kharlampovich SI
    Vopr Onkol; 1974; 20(4):98-9. PubMed ID: 4439824
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined action of antiblastoma preparations on lysozyme activity in animal organs].
    Ievenko NV; Tsyganenko AIa
    Antibiotiki; 1978 Feb; 23(2):153-8. PubMed ID: 415659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative action of polymer preparations and sarcolysine on hematopoiesis in mice].
    Samoilovich LI; Zubova OV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1973; 110(2):42-5. PubMed ID: 4721630
    [No Abstract]   [Full Text] [Related]  

  • 16. [Distribution of thio-TEPA S35 after intravenous and intra-arterial administration (experimental study)].
    Gasparian SA; Gol'dman BG; Moroz LM
    Vopr Onkol; 1966 Apr; 12(4):65-9. PubMed ID: 4971004
    [No Abstract]   [Full Text] [Related]  

  • 17. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of the circadian rhythm of cell division in the action of sarcolysine on transplantable rat sarcomas].
    Svinogeeva TP; Kharlampovich SI
    Vopr Onkol; 1973; 19(12):62-5. PubMed ID: 4786892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological analysis on the role of endogenous vasoactive substances in regulating mechanism of microcirculatory dynamics in oral region. Effect of bradykinin on isolated canine lingual arteries].
    Koike A; Todoki K; Takada H; Okabe E; Ito H
    Kanagawa Shigaku; 1987 Jun; 22(1):212-7. PubMed ID: 3269422
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicity and antineoplastic activity of asalei (ethyl ester of acetyl-sarcolysine-L-leucine).
    Larionov LF; Bukharova IK; Shamaeva EM
    Fed Proc Transl Suppl; 1966; 25(1):77-8. PubMed ID: 5215810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.